Research Institute of the McGill University Health Centre
Dr. Behr is a clinician-scientist with appointments of Full Professor in the Department of Medicine and Associate member in the departments of Epidemiology & Biostatistics as well as Microbiology & Immunology. He was the founding Director of the McGill International TB Centre and led it from 2012 to 2018. He is the Associate Program Leader of the Infectious Diseases and Immunity in Global Health Program at the Research Institute of the McGill University Health Centre since 2016. He is Director of the McGill Infectious Diseases Division andthe McGill Interdisciplinary Initiative in Infection and Immunity (McGill-i4).
Dr. Behr trained at the University of Toronto, Queen’s, McGill and Stanford. His work has been recognized by election into the Canadian Academy of Health Sciences, the Royal Society of Canada, the American Society for Clinical Investigation and the American Academy of Microbiology. Dr. Behr’s lab uses bacterial genomic methodologies to study the epidemiology and pathogenesis of tuberculosis and other mycobacterial diseases. His work has helped clarify the natural history of TB infection and disease, determine the basis of BCG attenuation and understand the innate immune response to the mycobacterial cell wall.